Next Article
Promising early trials of immune therapy on solid tumours
CAR T-cell therapy—where doctors reprogram immune cells to target cancer—has already helped people beat blood cancers.
Now, researchers are testing it on solid tumors like stomach and brain cancers.
Early results from China and the US are encouraging, with some patients seeing their tumors shrink and living longer.
Challenges in treating solid tumors
Treating solid tumors is trickier since immune cells have to get through dense tissue, and cancer markers often overlap with healthy cells.
Dr. Hasmukh Jain from Tata Memorial Hospital highlights these hurdles.
Researchers are using AI tools to find better targets, and Indian startup ImmunoACT is working on therapies for tricky cancers like gastric and brain tumors, showing that progress is happening step by step.